Skip to main content Accesibility Help
×
×
Home

Clinical significance of neurological abnormalities in psychosis

  • Marco M. Picchioni and Paola Dazzan
Summary

The neurological deficits in sensory and motor function in schizophrenia have been described using a confusing variety of terms, reflecting their uncertain relevance and significance to psychosis. In this article we explore the nature of neurological abnormalities in psychosis, describe their assessment and suggest their potential relevance for clinician and patient. We propose that the assessment of neurological abnormalities and extrapyramidal side-effects should figure in the assessment of any patient with psychosis, particularly at illness onset. Furthermore, we suggest that neurological abnormalities can inform prognostic predictions and help to identify patients with more complex future care needs.

  • View HTML
    • Send article to Kindle

      To send this article to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle. Find out more about sending to your Kindle.

      Note you can select to send to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

      Find out more about the Kindle Personal Document Service.

      Clinical significance of neurological abnormalities in psychosis
      Available formats
      ×
      Send article to Dropbox

      To send this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Dropbox.

      Clinical significance of neurological abnormalities in psychosis
      Available formats
      ×
      Send article to Google Drive

      To send this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Google Drive.

      Clinical significance of neurological abnormalities in psychosis
      Available formats
      ×
Copyright
Corresponding author
Dr P. Dazzan, Division of Psychological Medicine, PO40, Institute of Psychiatry, De Crespigny Park, London SE5 8AF, UK. Email: paola.dazzan@kcl.ac.uk
Footnotes
Hide All

Declaration of Interest

None.

Footnotes
References
Hide All
Allin, M, Matsumoto, H, Santhouse, AM et al (2001) Cognitive and motor function and the size of the cerebellum in adolescents born very pre-term. Brain; 124: 60–6.
Arango, C, Bartko, JJ, Gold, JM et al (1999) Prediction of neuropsychological performance by neurological signs in schizophrenia. American Journal of Psychiatry; 156: 1349–57.
Arango, C, Kirkpatrick, B, Buchanan, RW (2000) Neurological signs and the heterogeneity of schizophrenia. American Journal of Psychiatry; 157: 560–5.
Bachmann, S, Bottmer, C, Schroder, J (2005) Neurological soft signs in first-episode schizophrenia: a follow-up study. American Journal of Psychiatry; 162: 2337–43.
Barkus, E, Stirling, J, Hopkins, R et al (2006) The presence of neurological soft signs along the psychosis proneness continuum. Schizophrenia Bulletin; 32: 573–7.
Barnes, TR (1989) A rating scale for drug-induced akathisia. British Journal of Psychiatry; 154: 672–6.
Boks, MP, Liddle, PF, Russo, S et al (2003) Influence of antipsychotic agents on neurological soft signs and dyskinesia in first episode psychosis. Psychiatry Research; 119: 167–70.
Boks, MP, Liddle, PF, Burgerhof, JG et al (2004) Neurological soft signs discriminating mood disorders from first episode schizophrenia. Acta Psychiatrica Scandinavica; 110: 2935.
Bombin, I, Arango, C, Buchanan, RW (2005) Significance and meaning of neurological signs in schizophrenia: two decades later. Schizophrenia Bulletin; 31: 962–77.
Borgwardt, SJ, Radue, EW, Gotz, K et al (2006) Radiological findings in individuals at high risk of psychosis. Journal of Neurology, Neurosurgery, and Psychiatry; 77: 229–33.
Buchanan, RW, Heinrichs, DW (1989) The Neurological Evaluation Scale (NES): a structured instrument for the assessment of neurological signs in schizophrenia. Psychiatry Research; 27: 335–50.
Caligiuri, MP, Lohr, JB (1997) Instrumental motor predictors of neuroleptic-induced Parkinsonism in newly medicated schizophrenia patients. Journal of Neuropsychiatry and Clinical Neurosciences; 9: 562–7.
Cannon, M, Walsh, E, Hollis, C et al (2001) Predictors of later schizophrenia and affective psychosis among attendees at a child psychiatry department. British Journal of Psychiatry; 178: 420–6.
Cantor-Graae, E, McNeil, TF, Rickler, KC et al (1994) Are neurological abnormalities in well discordant monozygotic co-twins of schizophrenic subjects the result of perinatal trauma? American Journal of Psychiatry; 151: 1194–9.
Cantor-Graae, E, Ismail, B, McNeil, TF (2000) Are neurological abnormalities in schizophrenic patients and their siblings the result of perinatal trauma? Acta Psychiatrica Scandinavica; 101: 142–7.
Carnahan, RM, Lund, BC, Perry, PJ et al (2006) Increased risk of extrapyramidal side-effect treatment associated with atypical antipsychotic polytherapy. Acta Psychiatrica Scandinavica; 113: 135–41.
Casey, DE (2006) Implications of the CATIE trial on treatment: extrapyramidal symptoms. CNS Spectrums; 11: 2531.
Chen, EY, Shapleske, J, Luque, R et al (1995) The Cambridge Neurological Inventory: a clinical instrument for assessment of soft neurological signs in psychiatric patients. Psychiatry Research; 56: 183204.
Convit, A, Volavka, J, Czobor, P et al (1994) Effect of subtle neurological dysfunction on response to haloperidol treatment in schizophrenia. American Journal of Psychiatry; 151: 4956.
Crow, TJ, Done, DJ, Sacker, A (1995) Childhood precursors of psychosis as clues to its evolutionary origins. European Archives of Psychiatry and Clinical Neuroscience; 245: 61–9.
Dazzan, P, Murray, RM (2002) Neurological soft signs in first-episode psychosis: a systematic review. British Journal of Psychiatry; 181 (suppl 43): s507.
Dazzan, P, Morgan, KD, Orr, KG et al (2004) The structural brain correlates of neurological soft signs in AESOP first-episode psychoses study. Brain; 127: 143–53.
Dazzan, P, Morgan, KD, Orr, KG et al (2005) Different effects of typical and atypical antipsychotics on grey matter in first episode psychosis: the AESOP study. Neuropsychopharmacology; 30: 765–74.
Dazzan, P, Lloyd, T, Morgan, KD et al (2008) Neurological abnormalities and cognitive ability in first-episode psychosis. British Journal of Psychiatry; 193: 197202.
Egan, MF, Hyde, TM, Bonomo, JB et al (2001) Relative risk of neurological signs in siblings of patients with schizophrenia. American Journal of Psychiatry; 158: 1827–34.
Emsley, RA, Turner, HJ, Oosthuizen, PP et al (2005) Neurological abnormalities in first-episode schizophrenia: temporal stability and clinical and outcome correlates. Schizophrenia Research; 75: 3544.
Erhart, SM, Young, AS, Marder, SR et al (2005) Clinical utility of magnetic resonance imaging radiographs for suspected organic syndromes in adult psychiatry. Journal of Clinical Psychiatry; 66: 968–73.
Galderisi, S, Maj, M, Mucci, A et al (2002) Historical, psychopathological, neurological, and neuropsychological aspects of deficit schizophrenia: a multicenter study. American Journal of Psychiatry; 159: 983–90.
Gangadhar, BN, Jayakumar, PN, Venkatasubramanian, G et al (2006) Developmental reflexes and 31P Magnetic Resonance Spectroscopy of basal ganglia in antipsychotic-naive schizophrenia. Progress in Neuropsychopharmacology and Biological Psychiatry; 30: 910–3.
Gourion, D, Goldberger, C, Olie, JP et al (2004) Neurological and morphological anomalies and the genetic liability to schizophrenia: a composite phenotype. Schizophrenia Research; 67: 2331.
Heinrichs, DW, Buchanan, RW (1988) Significance and meaning of neurological signs in schizophrenia. American Journal of Psychiatry; 145: 11–8.
Ho, BC, Mola, C, Andreasen, NC (2004) Cerebellar dysfunction in neuroleptic naive schizophrenia patients: clinical, cognitive, and neuroanatomic correlates of cerebellar neurologic signs. Biological Psychiatry; 55: 1146–53.
Hollister, LE, Shah, NN (1996) Structural brain scanning in psychiatric patients: a further look. Journal of Clinical Psychiatry; 57: 241–4.
Ismail, BT, Cantor-Graae, E, Cardenal, S et al (1998) Neurological abnormalities in schizophrenia: clinical, etiological and demographic correlates. Schizophrenia Research; 30: 229–38.
Ismail, B, Cantor-Graae, E, McNeil, TF (2001) Neurodevelopmental origins of tardivelike dyskinesia in schizophrenia patients and their siblings. Schizophrenia Bulletin; 27: 629–41.
Keshavan, MS, Sanders, RD, Sweeney, JA et al (2003) Diagnostic specificity and neuroanatomical validity of neurological abnormalities in first-episode psychoses. American Journal of Psychiatry; 160: 1298–304.
Kraepelin, E (1919) Dementia Praecox and Paraphrenia. Livingston.
Lawrie, SM, Byrne, M, Miller, P et al (2001) Neurodevelopmental indices and the development of psychotic symptoms in subjects at high risk of schizophrenia. British Journal of Psychiatry; 178: 524–30.
Lencer, R, Eismann, G, Kasten, M et al (2004) Family history of primary movement disorders as a predictor for neuroleptic-induced extrapyramidal symptoms. British Journal of Psychiatry; 185: 465–71.
Liddle, PF (1987) The symptoms of chronic schizophrenia. A re-examination of the positive-negative dichotomy. British Journal of Psychiatry; 151: 145–51.
Lieberman, JA, Stroup, TS, McEvoy, JP et al (2005) Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. New England Journal of Medicine; 353: 1209–23.
McCreadie, RG, Thara, R, Padmavati, R et al (2002) Structural brain differences between never-treated patients with schizophrenia, with and without dyskinesia, and normal control subjects: a magnetic resonance imaging study. Archives of General Psychiatry; 59: 332–6.
McCreadie, RG, Srinivasan, TN, Padmavati, R et al (2005) Extrapyramidal symptoms in unmedicated schizophrenia. Journal of Psychiatry Research; 39: 261–6.
McNeil, TF, Cantor-Graae, E (2000) Neuromotor markers of risk for schizophrenia. Australian and New Zealand Journal of Psychiatry; 34 (suppl): s8690.
Miller, DD, McEvoy, JP, Davis, SM et al (2005) Clinical correlates of tardive dyskinesia in schizophrenia: baseline data from the CATIE schizophrenia trial. Schizophrenia Research; 80: 3343.
Mohr, F, Hubmann, W, Albus, M et al (2003) Neurological soft signs and neuropsychological performance in patients with first episode schizophrenia. Psychiatry Research; 121: 2130.
Mueller, C, Rufer, M, Moergeli, H et al (2006) Brain imaging in psychiatry – a study of 435 psychiatric in-patients at a university clinic. Acta Psychiatrica Scandinavica; 114: 91100.
Nasrallah, HA, Tippin, J, McCalley-Whitters, M (1983) Neurological soft signs in manic patients. A comparison with schizophrenic and control groups. Journal of Affective Disorders; 5: 4550.
National Institute of Mental Health (1976) Abnormal Involuntary Movement Scale (AIMS). In ECDEU: Assessment Manual for Psychopharmacology (ed Guy, W) pp 534–7. US Department of Health, Education, and Welfare.
Picchioni, MM, Toulopoulou, T, Landau, S et al (2006) Neurological abnormalities in schizophrenic twins. Biological Psychiatry; 59: 341–8.
Potvin, S, Pampoulova, T, Mancini-Marie, A et al (2006) Increased extrapyramidal symptoms in patients with schizophrenia and a comorbid substance use disorder. Journal of Neurology, Neurosurgery, and Psychiatry; 77: 796–8.
Prikryl, R, Ceskova, E, Kasparek, T et al (2006) Neurological soft signs, clinical symptoms and treatment reactivity in patients suffering from first episode schizophrenia. Journal of Psychiatry Research; 40: 141–6.
Rao, H, Di, X, Chan, RC et al (2008) A regulation role of the prefrontal cortex in the fist-edge-palm task: evidence from functional connectivity analysis. Neuroimage; 41: 1345–51.
Rossi, A, De Cataldo, S, Di Michele, V et al (1990) Neurological soft signs in schizophrenia. British Journal of Psychiatry; 157: 735–9.
Rubin, P, Vorstrup, S, Hemmingsen, R et al (1994) Neurological abnormalities in patients with schizophrenia or schizophreniform disorder at first admission to hospital: correlations with computerized tomography and regional cerebral blood flow findings. Acta Psychiatrica Scandinavica; 90: 385–90.
Sachdev, P, Brodaty, H, Rose, N et al (1999) Schizophrenia with onset after age 50 years. 2: Neurological, neuropsychological and MRI investigation. British Journal of Psychiatry; 175: 416–21.
Sanders, RD, Schuepbach, D, Goldstein, G et al (2004) Relationships between cognitive and neurological performance in neuroleptic-naive psychosis. Journal of Neuropsychiatry and Clinical Neurosciences; 16: 480–7.
Scheffer, RE (2004) Abnormal neurological signs at the onset of psychosis. Schizophrenia Research; 70: 1926.
Schroder, J, Niethammer, R, Geider, FJ et al (1991) Neurological soft signs in schizophrenia. Schizophrenia Research; 6: 2530.
Schroder, J, Wenz, F, Schad, LR et al (1995) Sensorimotor cortex and supplementary motor area changes in schizophrenia. A study with functional magnetic resonance imaging. British Journal of Psychiatry; 167: 197201.
Schubert, EW, McNeil, TF (2004) Prospective study of neurological abnormalities in offspring of women with psychosis: birth to adulthood. American Journal of Psychiatry; 161: 1030–7.
Schubert, EW, McNeil, TF (2005) Neuropsychological impairment and its neurological correlates in adult offspring with heightened risk for schizophrenia and affective psychosis. American Journal of Psychiatry; 162: 758–66.
Simpson, GM, Angus, JWS (1970) A rating scale for extrapyramidal side effects. Acta Psychiatrica Scandinavica; 212 (suppl): 1119.
Smith, RC, Kadewari, RP, Rosenberger, JR et al (1999) Nonresponding schizophrenia: differentiation by neurological soft signs and neuropsychological tests. Schizophrenia Bulletin; 25: 813–25.
Srinivasan, TN, Thara, R, Padmavathi, R et al (2001) Relationship of extrapyramidal symptoms to age at onset and drug treatment in middle-aged and elderly schizophrenic patients. Schizophrenia Research; 47: 6975.
Tarbox, SI, Pogue-Geile, MF (2006) Spontaneous dyskinesia and familial liability to schizophrenia. Schizophrenia Research; 81: 125–37.
Tarsy, D, Baldessarini, RJ (2006) Epidemiology of tardive dyskinesia: is risk declining with modern antipsychotics? Movement Disorders; 21: 589–98.
Tosato, S, Dazzan, P (2005) The psychopathology of schizophrenia and the presence of neurological soft signs: a review. Current Opinion in Psychiatry; 18: 285–8.
Venkatasubramanian, G, Latha, V, Gangadhar, BN et al (2003) Neurological soft signs in never-treated schizophrenia. Acta Psychiatrica Scandinavica; 108: 144–6.
Walterfang, M, Velakoulis, D (2005) Cortical release signs in psychiatry. Australian and New Zealand Journal of Psychiatry; 39: 317–27.
Weinberger, DR, Wyatt, RJ (1982) Cerebral ventricular size: a biological marker for sub-typing chronic schizophrenia. In Biological Markers in Psychiatry and Neurology (ed Usdin, EE) pp 505–12. Pergamon Press.
Whitty, P, Clarke, M, Browne, S et al (2003) Prospective evaluation of neurological soft signs in first-episode schizophrenia in relation to psychopathology: state versus trait phenomena. Psychological Medicine; 33: 1479–84.
Whitty, P, Clarke, M, McTigue, O et al (2006) Diagnostic specificity and predictors of neurological soft signs in schizophrenia, bipolar disorder and other psychoses over the first 4 years of illness. Schizophrenia Research; 86: 110–7.
Wojcik, JD, Gelenberg, AJ, LaBrie, RA et al (1980) Prevalence of tardive dyskinesia in an outpatient population. Comprehensive Psychiatry; 21: 370–80.
Wonodi, I, Adami, HM, Cassady, SL et al (2004) Ethnicity and the course of tardive dyskinesia in outpatients presenting to the motor disorders clinic at the Maryland psychiatric research center. Journal of Clinical Psychopharmacology; 24: 592–8.
Yazici, AH, Demir, B, Yazici, KM et al (2002) Neurological soft signs in schizophrenic patients and their nonpsychotic siblings. Schizophrenia Research; 58: 241–6.
Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

BJPsych Advances
  • ISSN: 1355-5146
  • EISSN: 1472-1481
  • URL: /core/journals/bjpsych-advances
Please enter your name
Please enter a valid email address
Who would you like to send this to? *
×

Metrics

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed

Clinical significance of neurological abnormalities in psychosis

  • Marco M. Picchioni and Paola Dazzan
Submit a response

eLetters

No eLetters have been published for this article.

×

Reply to: Submit a response


Your details


Conflicting interests

Do you have any conflicting interests? *